Detalhe da pesquisa
1.
Tolerability, safety, pharmacokinetics, and efficacy of doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours: a phase 1 dose-escalation study.
Lancet Oncol
; 13(12): 1234-41, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23153506